GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » China Healthwise Holdings Ltd (HKSE:00348) » Definitions » 3-Year EPS without NRI Growth Rate

China Healthwise Holdings (HKSE:00348) 3-Year EPS without NRI Growth Rate : -33.00% (As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is China Healthwise Holdings 3-Year EPS without NRI Growth Rate?

China Healthwise Holdings's EPS without NRI for the six months ended in Dec. 2023 was HK$-0.02.

During the past 3 years, the average EPS without NRI Growth Rate was -33.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was -8.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of China Healthwise Holdings was 76.00% per year. The lowest was -84.20% per year. And the median was -18.35% per year.


Competitive Comparison of China Healthwise Holdings's 3-Year EPS without NRI Growth Rate

For the Pharmaceutical Retailers subindustry, China Healthwise Holdings's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Healthwise Holdings's 3-Year EPS without NRI Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, China Healthwise Holdings's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where China Healthwise Holdings's 3-Year EPS without NRI Growth Rate falls into.



China Healthwise Holdings 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


China Healthwise Holdings  (HKSE:00348) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


China Healthwise Holdings 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of China Healthwise Holdings's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


China Healthwise Holdings (HKSE:00348) Business Description

Traded in Other Exchanges
N/A
Address
168-200 Connaught Road Central, Unit 1209, Shun Tak Centre, West Tower, Hong Kong, HKG
China Healthwise Holdings Ltd is an investment holding company. It operates in three segments: Chinese health products, Money lending business, and investment in financial instruments. The majority of its revenue comes from trading in Chinese health products, which include pharmaceutical products, ginseng, and dried seafood products. The company's geographical segments are Hong Kong and the PRC, of which key revenue is derived from Hong Kong.

China Healthwise Holdings (HKSE:00348) Headlines

No Headlines